SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022629
Filing Date
2022-08-15
Accepted
2022-08-15 09:37:01
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 815435
2 ex31-1.htm EX-31.1 20269
3 ex31-2.htm EX-31.2 19624
4 ex32-1.htm EX-32.1 5852
5 ex32-2.htm EX-32.2 5412
  Complete submission text file 0001493152-22-022629.txt   4462113

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gtbp-20220630.xsd EX-101.SCH 45306
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gtbp-20220630_cal.xml EX-101.CAL 41656
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gtbp-20220630_def.xml EX-101.DEF 154717
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gtbp-20220630_lab.xml EX-101.LAB 352114
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gtbp-20220630_pre.xml EX-101.PRE 242766
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 611879
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 221162898
SIC: 2834 Pharmaceutical Preparations